Curiously, protection against pathological cancer processes was concentration dependent and exhibited a hormetic pattern with concentrations higher than 250 μg GAE/mL exerting the opposite effect, i.e., inducing the interaction between HRAS/BRAF above the levels observed for the untreated condition via a mechanism that still remains to be elucidated. The gene discussed is BRAF; the disease is cancer.